4/1/2023China Further Intensifies Healthcare Cost Containment and Price Contro...

3/31/2023Projections of Future Life Expectancy in China Up to 2035: A Modelling...

3/31/2023CDE Issues the Working Procedures for Accelerating Evaluation of Marke...

3/31/2023NSFC, Gates Foundation Launch Joint Fund to Improve Vaccine Regulatory...

3/31/2023Recent Executive Moves

3/31/2023Drug R&D and Product Registration News Digest March 2023 (5)

3/31/2023Financial-related Company News Digest (March 2023)

3/30/2023AstraZeneca, KYM Biosciences Complete Licensing Deal for Anticancer Dr...

3/30/2023Apollomics Announces Closing of Business Combination and Listing on Na...

3/30/2023IQVIA: Chinese Retail Pharmacy Sales up 5.2% in MAT Q4/2022

3/30/2023China Continued to Dominate the Hurun Global Rich List 2023, Highlight...

3/30/2023Central Government Issues the Notice on Further Facilitating Medical E...

3/30/2023Boehringer Ingelheim Remains Confident of Its China Prospects Despite ...

3/30/2023Rxilient and Junshi form JV to Develop and Commercialize Toripalimab i...

3/29/2023JPO Publicizes 8th VBP Tender Outcome, Which Cuts Average Price by 56%

3/29/2023Investing in China's Healthcare Sector (China Briefing)

3/28/2023Uptake of Hepatitis C Direct-Acting Antiviral Treatment in China: A Re...

3/28/2023CDE Issues the Technical Guidelines for the Application of Physiologic...

3/28/2023NHSA Issues the NHSA Notice on Improving the Price Formation Mechanism...

3/28/2023Chinese Scientists Develop New Vaccine Strategy by Entrapping Live Vir...

3/27/2023BioNTech and Oncoc4 Sign Strategic Collaboration for Novel Checkpoint ...

3/27/2023NCC: China's Tumor Registration System Covers 1.407B Population

3/27/2023AstraZeneca to Further Expand R&D Presence in China

3/27/2023Hepalink's OncoVent Enter License Deal with Orient EuroPharma for Oreg...

3/24/2023InvoX Pharma's F-star Announces 2nd Licence Deal with Takeda

3/24/2023Brii Bio Drops Once-promising COVID Cocktail for Variants

3/24/2023AstraZeneca's Blood Cancer Drug Calquence Gets Conditional Approval in...

3/24/2023NMPA Publishes the 2022 Annual Report for Adverse Drug Reaction Monito...

3/24/2023NMPA Issues the Procedures for Adjustment of Published Reference Formu...

3/24/2023CDE Issues the "Common Pharmacy Issues and Related Technical Requireme...

Page:108/775 Total number of articles:23249: [First][<<] [106] [107] [108] [109] [110] [>>] [End]